<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7230963\results\search\drugs\results.xml">
  <result pre="41 (40.1%) patients died. Of the 94 patients who received" exact="oseltamivir" post="therapy, 68 (72.3%) began taking oseltamivir 48 h after"/>
  <result pre="94 patients who received oseltamivir therapy, 68 (72.3%) began taking" exact="oseltamivir" post="48 h after the onset of illness. Of the"/>
  <result pre="conditions, clinical signs and symptoms, antiviral treatment course (oseltamivir or" exact="peramivir" post="therapy), results of laboratory tests and radiography findings at"/>
  <result pre="the 102 patients, three did not receive antiviral therapy (either" exact="oseltamivir" post="or peramivir). Of the 99 patients who received antiviral"/>
  <result pre="the 99 patients who received antiviral therapy, 89 patients received" exact="oseltamivir" post="and five received peramivir; five patients received both oseltamivir"/>
  <result pre="received oseltamivir and five received peramivir; five patients received both" exact="oseltamivir" post="and peramivir during their hospitalization. Of the 94 patients"/>
  <result pre="and five received peramivir; five patients received both oseltamivir and" exact="peramivir" post="during their hospitalization. Of the 94 patients who received"/>
  <result pre="peramivir during their hospitalization. Of the 94 patients who received" exact="oseltamivir" post="therapy, 68 (72.3%) began taking oseltamivir 48 h after"/>
  <result pre="94 patients who received oseltamivir therapy, 68 (72.3%) began taking" exact="oseltamivir" post="48 h after the onset of illness. Among the"/>
  <result pre="B virus infection. Of the 38 deceased patients who received" exact="oseltamivir" post="treatment, 76.3% of patients received oseltamivir more than 48"/>
  <result pre="deceased patients who received oseltamivir treatment, 76.3% of patients received" exact="oseltamivir" post="more than 48 h after onset of the illness"/>
  <result pre="of systematic reviews and/or meta analysesJ. Antimicrob. Chemother.2017722990300710.1093/jac/dkx27128961794 16.FryA.M.GoswamiD.NaharK.SharminA.T.RahmanM.GubarevaL.AzimT.BreseeJ.LubyS.P.BrooksW.A.Efficacy of" exact="oseltamivir" post="treatment started within 5 days of symptom onset to"/>
  <result pre="and Risk Factors for Fatal OutcomePLoS ONE2009410.1371/journal.pone.0006051 32.KumarA.Early versus late" exact="oseltamivir" post="treatment in severely ill patients with 2009 pandemic influenza"/>
  <result pre="N (%) 94 (92.2) 56 (91.8) 38 (92.7) &amp;gt;0.99 Use" exact="oseltamivir" post="≥48 h after onset of illness, N/total N (%)"/>
  <result pre="N (%) 10 (9.8) 8 (13.1) 2 (4.9) 0.793 Use" exact="peramivir" post="≥48 h after onset of illness, N/total N (%)"/>
 </snippets>
</snippetsTree>
